Website stats and analysis

Eric Elliott Chairman of the Board of Directors In his most recent role as Prime Therapeutics' President and Chief Executive Officer, Eric Elliott was responsible for all operating and strategic aspects of the full service pharmacy benefit management company. With approximately $ billion in annualized drug spend under management, Prime Therapeutics is the fourth largest...

2.48 Rating by Usitestat

voluntis.com was registered 2 decades 4 years ago. It has a alexa rank of #2,614,756 in the world. It is a domain having .com extension. It is estimated worth of $ 480.00 and have a daily income of around $ 2.00. As no active threats were reported recently, voluntis.com is SAFE to browse.

Traffic Report

Daily Unique Visitors: 335
Daily Pageviews: 670

Estimated Valuation

Income Per Day: $ 2.00
Estimated Worth: $ 480.00

Search Engine Indexes

Google Indexed Pages: Not Applicable
Yahoo Indexed Pages: Not Applicable
Bing Indexed Pages: Not Applicable

Search Engine Backlinks

Google Backlinks: Not Applicable
Bing Backlinks: Not Applicable
Alexa BackLinks: Not Applicable

Safety Information

Google Safe Browsing: No Risk Issues
Siteadvisor Rating: Not Applicable
WOT Trustworthiness: Very Poor
WOT Privacy: Very Poor
WOT Child Safety: Very Poor

Website Ranks & Scores

Alexa Rank: 2,614,756
PageSpeed Score: 89 ON 100
Domain Authority: 49 ON 100
Bounce Rate: Not Applicable
Time On Site: Not Applicable

Web Server Information

Hosted IP Address:

37.59.175.131

Hosted Country:

France FR

Location Latitude:

50.6942

Location Longitude:

3.17456

Search Engine Results For voluntis.com

Insulia

- https://insulia.com/

www.voluntis.com · Voluntis · Terms of Use · Insulia Privacy Policy · Contact us. Insulia® is a prescription-only software medical device intended for ...


Voluntis and Redox Enter Into New Partnership to Enable ...

- https://www.businesswire.com/news/home/20201029006021/en/Voluntis-and-Redox-Enter-Into-New-Partnership-to-Enable-Interoperability-of-Digital-Therapeutics-With-Electronic-Health-Records

29 Oct 2020 ... Voluntis creates digital therapeutics that empower people with chronic conditions to self-manage their treatment every day, thus improving real- ...


Voluntis - Overview, News & Competitors | ZoomInfo.com

- https://www.zoominfo.com/c/voluntis-inc/352887592

View Voluntis (www.voluntis.com) location in Massachusetts, United States , revenue, industry and description. Find related and similar companies as well as  ...


Voluntis - Vesalius Biocapital

- https://www.vesaliusbiocapital.com/portfolio/voluntis

Voluntis develops state-of-the-art companion software to accompany and enhance a specific medical device or indication in the field of diabetes, coagulation ...


VOLUNTIS - Voluntis, a pioneer-turned-leader in digital...

- https://www.actusnews.com/en/voluntis/pr/2021/05/05/voluntis-a-pioneer-turned-leader-in-digital-therapeutics-sets-out-its-ambitions-for-profitable-growth

5 May 2021 ... Voluntis, a pioneer-turned-leader in digital therapeutics, sets out its ambitions for profitable growth · Cambridge (USA), Paris (France), · A decade&...


Voluntis Email Format | voluntis.com Emails - RocketReach

- https://rocketreach.co/voluntis-email-format_b5c70e6bf42e0d32

Voluntis uses 4 email formats: 1. first '.' [email protected] (96.3%). Enter a name to find & verify an email >>>


Monarch Medical Technologies and Voluntis Announce Partnership ...

- https://monarchmedtech.com/news/monarch-medical-technologies-and-voluntis-announce-partnership-to-provide-seamless-solution-for-insulin-dosing-across-the-continuum-of-care/

Providers Can Bridge the Gap Between Inpatient and Outpatient Glycemic Management with Monarch's EndoTool® Glucose Management System and Voluntis'


VOLUNTIS S.A. | live - Euronext Live

- https://live.euronext.com/en/ipo-showcase/voluntis-sa

Leveraging its Theraxium technology platform, Voluntis has designed and operates multiple digital therapeutics, especially in diabetes and oncology. Voluntis has ...


Oleena® | Digital therapeutic for cancer symptom management

- https://oleena.com/

... including prescriptions, diagnosis or treatment. Not to be used during pregnancy. © 2021 Voluntis. All rights reserved. Available On. www.voluntis.com.


VOLUNTIS

- https://www.voluntis.com/fr

Fondée en 2001 par 3 entrepreneurs, Voluntis est née d'une conviction forte ...


VOLUNTIS

- https://www.voluntis.com/

Therapies · trusted by leading pharmaceutical companies · At the forefront of the medical and digital revolutions, Voluntis is a pioneer in digital therapeutics &mid...


VOLUNTIS (EPA:VTX) Voluntis receives FDA 510(k) clearance for a ...

- https://www.webdisclosure.com/finance/stocks/voluntis/news/986999.html

7 Jun 2021 ... VOLUNTIS (EPA:VTX) Voluntis receives FDA 510(k) clearance for a new version of Insulia supporting an expanded range of basal insulins, ...


Voluntis S.A. - CMOCRO

- https://www.cmocro.com/company/Voluntis+S.A./index.html

At the forefront of the medical and digital revolutions, Voluntis is a pioneer of companion software. They design prescription applications that embed medical ...


Voluntis (ENXTPA:ALVTX) - Share price, News & Analysis - Simply ...

- https://simplywall.st/stocks/fr/healthcare/epa-alvtx/voluntis-shares

Executive Summary. Voluntis S.A. develops digital therapeutic solutions for diabetes, oncology, and other therapeutic areas in France and the United States.


Insulia diabetes management companion – Apps on Google Play

- https://play.google.com/store/apps/details?id=insulia.diabetes.eu&hl=en_IE

When you have type 2 diabetes, calculating your daily dose of basal insulin can be challenging. Insulia® makes it easier by doing the calculations for you.


Voluntis FDA Filings - FDA.report

- https://fda.report/Company/Voluntis

This page includes the latest FDA filings for Voluntis. Currently, you will find the latest 100 filings for Premarket Notifications, Premarket Applications, De Novo ...


VOLUNTIS SA Share Price - ALVTX Share Price - Stockopedia

- https://www.stockopedia.com/share-prices/voluntis-sa-EPA:ALVTX/

Voluntis SA develops digital solutions for diabetes, respiratory diseases, cancer, anticoagulation and hemophilia. Its product portfolio includes Insulia, a ...


Voluntis — Oxeon Partners

- https://www.oxeonpartners.com/voluntis

SUMMARY: Voluntis designs prescription applications that embed medical intelligence in the smartphones of people suffering from chronic and rare diseases.


Voluntis Announces New Pharma Collaboration in Oncology

- https://apnews.com/19c4b338ec8f4c10831da1462eabe565

18 Dec 2019 ... Voluntis (Paris:VTX) (Euronext Paris, Ticker: VTX - ISIN: FR0004183960), a leader in digital therapeutics, announced today a collaboration with ...


9VO-FF: Voluntis SA - Stock Price, Quote and News - CNBC

- https://www.cnbc.com/quotes/9VO-FF

Get Voluntis SA (9VO-FF:Frankfurt Stock Exchange) real-time stock quotes, news, price and financial information from CNBC.


Voluntis: Promising First-half Results for 2020 and Record ...

- https://www.marketscreener.com/quote/stock/VOLUNTIS-43536396/news/Voluntis-Promising-First-half-Results-for-2020-and-Record-Commercial-Invoicing-31379033/

29 Sep 2020 ... Voluntis (Paris:VTX) (Euronext Paris, Ticker: VTX - ISIN: FR0004183960), a leader in digital therapeutics, today announced its results for the ...


Voluntis | Tracxn

- https://tracxn.com/d/companies/voluntis.com

28 May 2021 ... Voluntis provides SaaS with API to medical devices MedTech companies & pharmaceuticals. Doctors give therapeutic education to their ...

Page Resources Breakdown

Homepage Links Analysis

Voluntis innovates healthcare solutions by embedding connectivity in therapeutics and medical intelligence in software.
voluntis, editeur de logiciel médical, hébergeur de données de santé, logicielmédical, gestion de la relation patient, relation patient médecin, solutions thérapeutiques logicielles, dispositifs médicaux logiciels, traitement innovant, plateforme, suite logicielle, call center medicalisé, diabeo, logiciel de suivi patient, suivi de maladies chroniques, télésurveillance, matériovigilance, suivi du diabète sur mobile, santé mobile, web, multi canal, suivi dactivité de call center médicaux, logiciel saas, saas santé, e santé, companion software, healthcare solutions, connectivity, medical intelligence, software, medical and digital revolution, m health, improve patient experience, real life outcomes, interoperability of devices, coaching messages, change behaviors, engage patients, symptoms tracker, monitor quality of life, monitor side effects, bidirectional data flow, support safety, support compliant use, therapeutic education, personalized dosage, adjust treatment remotely, prevent acute events, configurable dashboard, evaluate treatment efficacy, stratify high risk patients, real life data, evidence treatment effectiveness, insulin therapy manager, ce mark, telesage, telediab, coaguchek, inr self testing device, objets de la nouvelle france industrielle, up and coming company award, medpassport, enhance medical practices, enhance quality of care, pierre leurent, romain marmot, geneviève dorsay, etienne vial, olivier berrouiguet, alexandre capet, personalized medicine, big data, smartphone and tablet proliferation, quantified self, data driven medicine, patients empowerment, collaborative interactions, remote medical practice, innovative payer model, digital distribution channel, integrated care delivery, multi channel, connected therapeutics, telehealth, cloud, iso13485, sanofi

Website Inpage Analysis

H1 Headings: 11 H2 Headings: 29
H3 Headings: 23 H4 Headings: 6
H5 Headings: Not Applicable H6 Headings: Not Applicable
Total IFRAMEs: 1 Total Images: 47
Google Adsense: Not Applicable Google Analytics: UA-21320491-1

Two Phrase Analysis

Words Occurrences Density Possible Spam
of the 21 0.44 % No
is a 18 0.377 % No
in the 17 0.356 % No
years of 17 0.356 % No
digital therapeutics 17 0.356 % No
more than 13 0.272 % No
experience in 13 0.272 % No
of experience 12 0.251 % No
medical device 10 0.209 % No
management and 10 0.209 % No
medical devices 9 0.188 % No
as a 9 0.188 % No
on the 9 0.188 % No
such as 8 0.167 % No
and a 8 0.167 % No
a graduate 8 0.167 % No
graduate of 8 0.167 % No
digital therapeutic 8 0.167 % No
as well 7 0.147 % No
has more 7 0.147 % No

Four Phrase Analysis

Words Occurrences Density Possible Spam
years of experience in 9 0.188 % No
is a graduate of 8 0.167 % No
a graduate of the 5 0.105 % No
graduate of the Ecole 4 0.084 % No
has more than 15 4 0.084 % No
than 15 years of 4 0.084 % No
15 years of experience 4 0.084 % No
more than 15 years 4 0.084 % No
in the United States 3 0.063 % No
and the United States 3 0.063 % No
He is a graduate 3 0.063 % No
years of experience as 3 0.063 % No
of experience in the 3 0.063 % No
Centrale Paris engineering school 3 0.063 % No
WE INNOVATE HEALTHCARE TO 3 0.063 % No
of experience as a 3 0.063 % No
Prior to joining Voluntis 3 0.063 % No
Syntec Numérique where he 2 0.042 % No
Numérique where he leads 2 0.042 % No
of Syntec Numérique where 2 0.042 % No

HTTP Header Analysis

Http-Version: 1.1
Status-Code: 200
Status: 200 OK
Date: Mon, 26 Apr 2021 23:11:18 GMT
Server: Apache/2.4.12 (Win32) OpenSSL/1.0.1l PHP/5.6.20
X-Powered-By: PHP/5.6.20
Expires: Thu, 19 Nov 1981 08:52:00 GMT
Cache-Control: no-store, no-cache, must-revalidate, post-check=0, pre-check=0
Pragma: no-cache
Transfer-Encoding: chunked
Content-Type: text/html; charset=UTF-8

Domain Information

Domain Registrar: Gandi SAS
Registration Date: 2000-05-03 2 decades 4 years 6 months ago
Last Modified: 2021-03-03 3 years 8 months 1 week ago

Domain Nameserver Information

Host IP Address Country
a.dns.gandi.net 173.246.98.1 United States United States
b.dns.gandi.net 213.167.229.1 Spain Spain
c.dns.gandi.net 217.70.179.1 France France

DNS Record Analysis

Host Type TTL Extra
voluntis.com A 297 IP: 37.59.175.131
voluntis.com NS 10800 Target: c.dns.gandi.net
voluntis.com NS 10800 Target: b.dns.gandi.net
voluntis.com NS 10800 Target: a.dns.gandi.net
voluntis.com SOA 10800 MNAME: a.dns.gandi.net
RNAME: hostmaster.gandi.net
Serial: 1602680220
Refresh: 10800
Retry: 3600
Expire: 604800
voluntis.com MX 28800 Target: voluntis-com.mail.protection.outlook.com
voluntis.com MX 28800 Priority: 10
Target: mail.voluntis.com
voluntis.com TXT 300 TXT: v=spf1 a a:usappmetrics.voluntis.com
include:eu.mailgun.org ip4:62.129.5.71
ip4:62.129.5.65
include:2089739.spf02.hubspotemail.net
include:spf.protection.outlook.com
include:mail.zendesk.com
include:servers.mcsv.net ~all
voluntis.com TXT 300 TXT:
MS=098FBB22F43F2E7289BAA6B2EA5C3D7639920
E3D
voluntis.com TXT 300 TXT:
gp++5h88qOUKikCv/3eogZlJ36eIvSqQmHb0zwkM
IDpmrPk0tHJlo1i2WuqiJCfPNPTPoHUHPYUt3A51
nVZA2g==
voluntis.com TXT 300 TXT:
google-site-verification=VuBBAsnta2wlrk-
O85guNlus-6GocMEINeO5kGM8Fe4
voluntis.com TXT 300 TXT:
cloudhealth=089e5d7f-af5f-400a-8e2e-01f6
eb8b81e9

Full WHOIS Lookup

Domain Name: VOLUNTIS.COM
Registry Domain ID:
26248211_DOMAIN_COM-VRSN
Registrar WHOIS Server:
whois.gandi.net
Registrar URL: http://www.gandi.net
Updated
Date: 2021-03-03T15:25:58Z
Creation Date:
2000-05-03T07:45:04Z
Registry Expiry Date:
2022-05-03T07:45:04Z
Registrar: Gandi SAS
Registrar IANA ID:
81
Registrar Abuse Contact Email:
[email protected]
Registrar Abuse Contact Phone:
+33.170377661
Domain Status: ok https://icann.org/epp#ok
Name
Server: A.DNS.GANDI.NET
Name Server: B.DNS.GANDI.NET
Name
Server: C.DNS.GANDI.NET
DNSSEC: unsigned
URL of the ICANN
Whois Inaccuracy Complaint Form: https://www.icann.org/wicf/
>>>
Last update of whois database: 2021-04-26T23:11:24Z

Similarly Ranked Websites

Hotel in Legian - Samsara Boutique Hotel

- samsarainn.com

Samsara Hotel in Legian Bali has a modern tropical colonial design with stylish architecture highlighted by fresh sleek interiors.

2,614,764   $ 480.00

LovKapra.com - Kaprařina online

- lovkapra.com

Vše o sportovním lovu kapra. Informace ze světa kaprařiny.

2,614,765   $ 480.00

In-Ear-Kopfhörer Test – Alle Anbieter aktuell aus 2019

- in-ear-kopfhoerer-testsieger.de

2,614,768   $ 480.00

powerHouse Books

- powerhousebooks.com

powerHouse Books, world-renowned and critically acclaimed publisher, is best known for a diverse publishing program—specialized in fine art, documentary, pop culture, fashion,...

2,614,848   $ 480.00

ErzieherIn.de - Das Portal für die Frühpädagogik

- erzieherin.de

Das Fachportal richtet sich an pädagogische Fachkräfte, Träger von Einrichtungen, Politik, Verwaltung und alle weiteren Akteure im Feld der Frühpädagogik.

2,614,889   $ 480.00